Understanding the unique mechanism of l-FMAU (Clevudine) against hepatitis B virus: molecular dynamics studies
- 1 December 2002
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 12 (23) , 3459-3462
- https://doi.org/10.1016/s0960-894x(02)00747-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Ribavirin's antiviral mechanism of action: lethal mutagenesis?Journal of Molecular Medicine, 2002
- Molecular Modeling and Biochemical Characterization Reveal the Mechanism of Hepatitis B Virus Polymerase Resistance to Lamivudine (3TC) and Emtricitabine (FTC)Journal of Virology, 2001
- In Vitro Inhibition of Hepadnavirus Polymerases by the Triphosphates of BMS-200475 and LobucavirAntimicrobial Agents and Chemotherapy, 1998
- Structure of a Covalently Trapped Catalytic Complex of HIV-1 Reverse Transcriptase: Implications for Drug ResistanceScience, 1998
- Inhibition of Epstein-Barr virus replication by a novel l-nucleoside, 2′-fluoro-5-methyl-β-l-arabinofuranosyluracilBiochemical Pharmacology, 1996
- Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-beta-L-2',3'-dideoxy-3'-thiacytidineAntimicrobial Agents and Chemotherapy, 1995
- Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virusAntimicrobial Agents and Chemotherapy, 1995
- The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesisCell, 1992
- Effects of (-)-2'-deoxy-3'-thiacytidine (3TC) 5'-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gammaAntimicrobial Agents and Chemotherapy, 1992
- 3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptaseAntimicrobial Agents and Chemotherapy, 1987